Related Experiment Videos

Metalloproteinase increases in the injured rat spinal cord

R C de Castro1, C L Burns, D J McAdoo

  • 1Department of Human Biological Chemistry and Genetics and the Marine Biomedical Institute, The University of Texas Medical Branch, Galveston 77555, USA.

Neuroreport
|November 30, 2000
PubMed

Insights

Matrix metalloproteinases MMP-9 and MMP-2 increase after spinal cord injury (SCI), with neutrophils being a key source of MMP-9. These enzymes likely contribute to extracellular matrix breakdown, impacting recovery.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Immunology

Background:

  • Spinal cord injury (SCI) triggers complex molecular responses.
  • Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and degradation.
  • Understanding MMP roles in SCI is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the expression and activity of specific matrix metalloproteinases (MMPs) following spinal cord injury.
  • To identify the cellular sources of MMPs, particularly MMP-9, in the injured spinal cord.
  • To assess the potential contribution of MMPs to extracellular matrix breakdown after SCI.

Main Methods:

  • Zymographic analysis was used to detect MMP-9 and MMP-2 activity.
  • Levels of MMP-3 were assessed, though found to be very low.
  • Immunohistochemistry or antibody-mediated ablation was employed to identify the cellular origin of MMP-9.

Main Results:

  • Matrix metalloproteinases MMP-9 and MMP-2 showed increased activity post-SCI.
  • MMP-9 activity peaked at 12-24 hours, while MMP-2 levels rose by 5 days.
  • Infiltrating neutrophils were identified as the primary source of MMP-9 activity.
  • Tissue inhibitor of metalloproteinases levels remained unchanged, potentially allowing increased MMP activity.

Conclusions:

  • Neutrophils are a significant source of MMP-9 following spinal cord injury.
  • MMP-9 and MMP-2 likely play a role in the degradation of the extracellular matrix after SCI.
  • These findings suggest MMPs as potential therapeutic targets for mitigating secondary damage in SCI.

Related Concept Videos